search
Back to results

Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)

Primary Purpose

Abdominal Aortic Aneurysm

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Cordis AAA Bilateral Device
Sponsored by
Cordis Corporation
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Abdominal Aortic Aneurysm

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: - Anatomic (stent-graft) Aortic Aneurysm Diameter > 4.5 cm Those aortic aneurysms < 4.5 cm that are at least 1.5 times the diameter of the aorta with a size increase of 5 mm or greater over a six month period will also be included for possible treatment. Aorto-iliac aneurysms in which the aortic aneurysm is < 4.5 cm but the iliac artery aneurysms are > 3.0 cm in diameter or there is evidence of recent expansion (5 mm or greater over a six month period) in iliac aneurysms < 3.0 cm. Saccular aortic aneurysms > 3.0 cm. Aortic Neck Diameter > 17 mm and < 28 mm (Phase I) Diameter > 14 mm and < 28 mm (Phase II) Angulation Neck Length < 45° > 15 mm <60° > 25 mm Iliac Arteries Diameter > 8 mm and < 18 mm (Phase I and Phase II) At least one common iliac artery with a cuff > 15 mm. Diameter Aortic Neck Common Iliac 26-28 mm 13-18 mm 23-25.9 mm 10-17 mm 20-22.9 mm 9-15 mm 17-19.9 mm 8-13 mm 14-16.9 mm 8-11mm *NOTE: An aortic diameter cannot be treated if the iliac diameter is not in the same range (e.g. 26-28 mm aortic necks must be in conjunction with 13-18 mm common iliacs). Anatomic (surgical controls) · Surgical controls will be required to meet only the aortic or aorto-iliac aneurysm size requirements for anatomic inclusion criteria. Aortic Aneurysm Diameter > 4.5 cm Those aortic aneurysms <4.5 cm that are at least 1.5 times the diameter of the aorta with a size increase of 5 mm or greater over a six month period will also be included for possible treatment. Aorto-iliac aneurysm in which the aortic aneurysm is <4.5 cm but the iliac artery aneurysm are >3.0 cm in diameter or there is evidence of recent expansion (5 mm or greater over a six month period) in iliac aneurysms <3.0 cm. Saccular aortic aneurysms > 3.0 cm. Clinical (stent-graft) Males and non-pregnant females > 40 years of age. Clinical (surgical controls) Surgical control patients will be required to meet all of the above-stated stent-graft clinical inclusion criteria. Exclusion Criteria: Anatomic (stent-graft) Aortic Aneurysm Diameter · < 4.5 cm that are not at least 1.5 times the diameter of the aorta with evidence of a size increase of 5 mm or greater within a six month period. Aorto-iliac Aneurysms < 3.0 cm in diameter unless evidence of recent expansion (5 mm or greater within a six month period). The iliac portion of the aneurysm extending to the bifurcation bilaterally which would necessitate covering both internal iliac arteries with the device. Aortic Neck Diameter < 17 mm and > 28 mm (Phase I) Diameter < 14 and >28 (Phase II) Thrombus lined Highly calcified NOTE: See inclusion criteria for length below the renals and degree of angulation. Iliac Arteries < 8 mm and > 18 mm (native) (Phase I and Phase II) Highly calcified (common) Neither common iliac artery with a cuff > 15 mm. NOTE: See inclusion criteria for aortic neck and iliac artery diameters. Anatomic (surgical controls) · Surgical controls will be excluded based only on the aortic or aorto-iliac aneurysm size requirements for anatomic exclusion criteria. Aortic Aneurysm Diameter · < 4.5 cm that are not at least 1.5 times the diameter of the aorta with evidence of a size increase of 5 mm or greater within a six month period. Aorto-Iliac Aneurysms < 3.0 cm in diameter unless evidence of recent expansion (5 mm or greater within a six month period). The iliac portion of the aneurysm extending to the bifurcation bilaterally which would necessitate surgically covering both internal iliac arteries. Clinical (stent-graft) Ruptured abdominal aortic aneurysm. Renal insufficiency - creatinine level > 2.5 mg/dl.

Sites / Locations

  • Mt. Sinai Hospital

Outcomes

Primary Outcome Measures

Primary success is defined as freedom from all of the following: rupture of aneurysm, enlargement of aneurysm > 0.5 cm on CT scan, with or without endoleak, as compared to any previous measurement, symptomatic aneurysm requiring treatment.
The absence of major complications at thirty days defined as arterial thrombosis, respiratory impairment, renal failure, myocardial infarction (M.I.) and stroke in combination with the absence of major complications at one year.

Secondary Outcome Measures

· Technical success defined as the successful access and deployment of the device at the appropriate anatomic location with aneurysmal exclusion determined by angiography at the time of deployment.
·

Full Information

First Posted
October 6, 2005
Last Updated
December 8, 2005
Sponsor
Cordis Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT00235118
Brief Title
Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)
Official Title
An Evaluation of the Safety and Effectiveness of the Cordis Bilateral AAA Device Compared to Open Surgical Repair for the Treatment of Abdominal Aortic Aneurysm
Study Type
Interventional

2. Study Status

Record Verification Date
October 2005
Overall Recruitment Status
Completed
Study Start Date
December 1999 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
February 2006 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Cordis Corporation

4. Oversight

5. Study Description

Brief Summary
The objective of this study is to assess the safety and effectiveness of the Cordis Bilateral AAA device and its Delivery System compared to open surgical repair for the treatment of Abdominal Aortic Aneurysm (AAA).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Abdominal Aortic Aneurysm

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
29 (false)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
Cordis AAA Bilateral Device
Primary Outcome Measure Information:
Title
Primary success is defined as freedom from all of the following: rupture of aneurysm, enlargement of aneurysm > 0.5 cm on CT scan, with or without endoleak, as compared to any previous measurement, symptomatic aneurysm requiring treatment.
Title
The absence of major complications at thirty days defined as arterial thrombosis, respiratory impairment, renal failure, myocardial infarction (M.I.) and stroke in combination with the absence of major complications at one year.
Secondary Outcome Measure Information:
Title
· Technical success defined as the successful access and deployment of the device at the appropriate anatomic location with aneurysmal exclusion determined by angiography at the time of deployment.
Title
·

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: - Anatomic (stent-graft) Aortic Aneurysm Diameter > 4.5 cm Those aortic aneurysms < 4.5 cm that are at least 1.5 times the diameter of the aorta with a size increase of 5 mm or greater over a six month period will also be included for possible treatment. Aorto-iliac aneurysms in which the aortic aneurysm is < 4.5 cm but the iliac artery aneurysms are > 3.0 cm in diameter or there is evidence of recent expansion (5 mm or greater over a six month period) in iliac aneurysms < 3.0 cm. Saccular aortic aneurysms > 3.0 cm. Aortic Neck Diameter > 17 mm and < 28 mm (Phase I) Diameter > 14 mm and < 28 mm (Phase II) Angulation Neck Length < 45° > 15 mm <60° > 25 mm Iliac Arteries Diameter > 8 mm and < 18 mm (Phase I and Phase II) At least one common iliac artery with a cuff > 15 mm. Diameter Aortic Neck Common Iliac 26-28 mm 13-18 mm 23-25.9 mm 10-17 mm 20-22.9 mm 9-15 mm 17-19.9 mm 8-13 mm 14-16.9 mm 8-11mm *NOTE: An aortic diameter cannot be treated if the iliac diameter is not in the same range (e.g. 26-28 mm aortic necks must be in conjunction with 13-18 mm common iliacs). Anatomic (surgical controls) · Surgical controls will be required to meet only the aortic or aorto-iliac aneurysm size requirements for anatomic inclusion criteria. Aortic Aneurysm Diameter > 4.5 cm Those aortic aneurysms <4.5 cm that are at least 1.5 times the diameter of the aorta with a size increase of 5 mm or greater over a six month period will also be included for possible treatment. Aorto-iliac aneurysm in which the aortic aneurysm is <4.5 cm but the iliac artery aneurysm are >3.0 cm in diameter or there is evidence of recent expansion (5 mm or greater over a six month period) in iliac aneurysms <3.0 cm. Saccular aortic aneurysms > 3.0 cm. Clinical (stent-graft) Males and non-pregnant females > 40 years of age. Clinical (surgical controls) Surgical control patients will be required to meet all of the above-stated stent-graft clinical inclusion criteria. Exclusion Criteria: Anatomic (stent-graft) Aortic Aneurysm Diameter · < 4.5 cm that are not at least 1.5 times the diameter of the aorta with evidence of a size increase of 5 mm or greater within a six month period. Aorto-iliac Aneurysms < 3.0 cm in diameter unless evidence of recent expansion (5 mm or greater within a six month period). The iliac portion of the aneurysm extending to the bifurcation bilaterally which would necessitate covering both internal iliac arteries with the device. Aortic Neck Diameter < 17 mm and > 28 mm (Phase I) Diameter < 14 and >28 (Phase II) Thrombus lined Highly calcified NOTE: See inclusion criteria for length below the renals and degree of angulation. Iliac Arteries < 8 mm and > 18 mm (native) (Phase I and Phase II) Highly calcified (common) Neither common iliac artery with a cuff > 15 mm. NOTE: See inclusion criteria for aortic neck and iliac artery diameters. Anatomic (surgical controls) · Surgical controls will be excluded based only on the aortic or aorto-iliac aneurysm size requirements for anatomic exclusion criteria. Aortic Aneurysm Diameter · < 4.5 cm that are not at least 1.5 times the diameter of the aorta with evidence of a size increase of 5 mm or greater within a six month period. Aorto-Iliac Aneurysms < 3.0 cm in diameter unless evidence of recent expansion (5 mm or greater within a six month period). The iliac portion of the aneurysm extending to the bifurcation bilaterally which would necessitate surgically covering both internal iliac arteries. Clinical (stent-graft) Ruptured abdominal aortic aneurysm. Renal insufficiency - creatinine level > 2.5 mg/dl.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael Marin, MD
Organizational Affiliation
MOUNT SINAI HOSPITAL
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mt. Sinai Hospital
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)

We'll reach out to this number within 24 hrs